Lyric Bio: $6.6 Million Seed Funding Closed To Advance Donor-Derived Therapeutics
By Amit Chowdhry ● Dec 4, 2025
Lyric Bio, a San Carlos–based biomanufacturing startup spun out of Prellis Biologics, has raised $6.6 million in oversubscribed seed financing to scale its next-generation production platform for donor-derived therapeutics. The round was led by The Venture Collective, with participation from Black Diamond Ventures, Draper Associates, Lucas Venture Group, Meiji Seika Pharma, SOSV, and other investors.